Listen: Podcast on The Fascinating History of Orphan Drugs

Learn how drugs that no pharmaceutical company wanted to make evolved into extremely lucrative products subsidized by the government.

Congressman Harry Waxman (left), Sharon Dobkin, Abbey Meyers (center), and Adam Seligman (right). / Image: Abbey Meyers
Congressman Harry Waxman (left), Sharon Dobkin, Abbey Meyers (center), and Adam Seligman (right). / Image: Abbey Meyers

A recent episode of the 99% Invisible podcast discussed the fascinating history of orphan drugs. Orphan drugs treat rare diseases that affect so few patients that commercial production doesn’t make financial sense for pharmaceutical companies. However, when a television producer with a rare disease got involved, the issue went viral and lead to reform. The 30-minute podcast is worth the listen, or you can opt for the written article; both are available here.

More in Pharmaceutical